Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03056833
Title Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

ovarian cancer

fallopian tube cancer

peritoneum cancer

Therapies

Carboplatin + Paclitaxel + Ribociclib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
UPMC Hillman Cancer Center Upper St. Clair Bethel Park Pennsylvania 15102 United States Details
UPMC Hillman Cancer Center Arnold Palmer at Mountain View Greensburg Pennsylvania 15601 United States Details
UPMC Hillman Cancer Center Arnold Palmer Medical at Norwin Irwin Pennsylvania 15642 United States Details
UPMC Hillman Cancer Center Arnold Palmer at Mt Pleasant Mount Pleasant Pennsylvania 15666 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 United States Details
UPMC Hillman Cancer Center Passavant (OHA) Pittsburgh Pennsylvania 15237 United States Details
UPMC Hillman Cancer Center Washington Washington Pennsylvania 15301 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field